A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- R W Johnson Pharmaceutical Research Institute
- Registration Number
- NCT00002249
- Locations
- 🇺🇸
R W Johnson Pharmaceutical Research Institute, Raritan, New Jersey, United States
Treatment Program for Anemia in AIDS Patients
Not Applicable
Completed
- Conditions
- HIV InfectionsCytopenias
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- R W Johnson Pharmaceutical Research Institute
- Registration Number
- NCT00002022
- Locations
- 🇺🇸
R W Johnson Pharmaceutical Research Institute, Raritan, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath